Sushruta Health Care And Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 3.70 M
as on 21-06-2024
- Paid Up Capital ₹ 3.68 M
as on 21-06-2024
- Company Age 14 Year, 8 Months
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 12.10 M
as on 21-06-2024
- Revenue -41.79%
(FY 2015)
- Profit 8.42%
(FY 2015)
- Ebitda -11.31%
(FY 2015)
- Net Worth 5.42%
(FY 2015)
- Total Assets -2.09%
(FY 2015)
About Sushruta Health Care And Diagnostics
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 3.70 M and a paid-up capital of Rs 3.68 M.
The company currently has active open charges totaling ₹1.21 Cr.
Rumpa Chakrabarty, Isha Bakshi, Bulbul Bhattacharya, and One other member serve as directors at the Company.
- CIN/LLPIN
U85191WB2010PTC141832
- Company No.
141832
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Feb 2010
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sushruta Health Care And Diagnostics?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rumpa Chakrabarty  | Director | 08-Sep-2020 | Current |
| Isha Bakshi | Director | 08-Sep-2020 | Current |
| Bulbul Bhattacharya | Director | 05-Feb-2010 | Current |
| Dhrubasish Bhattacharyya | Director | 05-Feb-2010 | Current |
Financial Performance and Corporate Structure Insights of Sushruta Health Care And Diagnostics.
Sushruta Health Care And Diagnostics Private Limited, for the financial year ended 2015, experienced significant reduction in revenue, with a 41.79% decrease. The company also saw a slight improvement in profitability, with a 8.42% increase in profit. The company's net worth moved up by a moderate rise of 5.42%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sushruta Health Care And Diagnostics?
In 2015, Sushruta Health Care And Diagnostics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
United Bank Of India Chowrasta (Behala) Branch Creation Date: 14 Nov 2011 | ₹1.18 Cr | Open |
Srei Equipment Finance Private Limited Creation Date: 15 Sep 2011 | ₹0.33 M | Open |
How Many Employees Work at Sushruta Health Care And Diagnostics?
Unlock and access historical data on people associated with Sushruta Health Care And Diagnostics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
As of Nov 25, 2014, Sushruta Health Care And Diagnostics has raised a total of ₹ 7.93 M, with the most recent deal valued at ₹ 4.81 M. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
